JCI vs KURA · P/E 44, rev $23.60B vs rev $20.9M
Johnson Controls International PLC (JCI) versus Kura Oncology Inc (KURA) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. KURA currently screens at market cap $861.1M.
Not investment advice. Open the JCI and KURA stock pages for the full models.
Not investment advice.